Literature DB >> 17708292

Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.

Kazuhiro Kondo1, Kazuo Chijiiwa, Motoaki Nagano, Masahide Hiyoshi, Masahiro Kai, Naoki Maehara, Jiro Ohuchida, Hiroyuki Nakao, Yoshiaki Ohkuwa.   

Abstract

BACKGROUND/AIMS: Various staging systems containing both the tumor and liver function factors for hepatocellular carcinoma (HCC) have been proposed. The aim of this study was to evaluate the appropriate staging system in patients received hepatic resection for HCC.
METHODOLOGY: The prognosis of the 235 patients who had undergone hepatectomy in these 15 years were analyzed according to the 7 staging systems, the Cancer of the Liver Italian Program (CLIP) score, the Barcelona Clinic Liver Cancer (BCLC) staging, the Groupe d'Etude et de Traitment du Carcinome Hépatocellulaire (GETCH) classification, the Chinese University Prognostic Index (CUPI) grade, the Japan Integrated Staging (JIS) score, modified JIS (mJIS) score, and Tokyo score. The capabilities to differentiate the postoperative survival between the neighboring score in each staging system were examined. Statistical analyses of the log-rank test, linear trend test, likelihood ratio (LR) test, Akaike Information Criteria (AIC), and Harrels' c-index were used.
RESULTS: The patients were widely distributed in the most of the staging system with the exceptions of GETCH classification and CUPI grade where almost all patients were classified to only the two groups. CLIP, JIS, mJIS, and Tokyo scores significantly differentiated the postoperative survival rate between 2 or 3 neighboring scores, whereas other staging systems only did between one. Statistical evaluations of prognostic stratification by the LR test, AIC, and Harrels' c-index showed that the JIS score system was the best among the 7 staging systems.
CONCLUSIONS: JIS score is the best staging system for HCC in patients who undergo hepatectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17708292

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

1.  Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Authors:  Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen M O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard L Saltz; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Hepatic resection is justified for elderly patients with hepatocellular carcinoma.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Mayumi Funagayama; Masahiro Kai; Kazuhiro Otani; Jiro Ohuchida
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 3.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  Staging systems for hepatocellular carcinoma: Current status and future perspectives.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Hisao Tajiri
Journal:  World J Hepatol       Date:  2015-03-27

5.  Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified?

Authors:  Shuang Wei; Xiaoyi Hao; Daqian Zhan; Min Xiong; Kaiyan Li; Xiaoping Chen; Zhiyong Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

6.  HCC in older patients.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 7.  Treatment of hepatocellular carcinoma: a systematic review.

Authors:  Shibo Lin; Katrin Hoffmann; Peter Schemmer
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

8.  Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Hepatol Int       Date:  2009-12-24       Impact factor: 6.047

9.  Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma.

Authors:  Heung Cheol Kim; Ki Tae Suk; Dong Joon Kim; Jai Hoon Yoon; Yeon Soo Kim; Gwang Ho Baik; Jin Bong Kim; Chang Hoon Kim; Hotaik Sung; Jong Young Choi; Kwang Hyub Han; Seung Ha Park
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  Comparative performances of staging systems for early hepatocellular carcinoma.

Authors:  Hari Nathan; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Pietro Majno; Luca Aldrighetti; Carlo Pulitano; Laura Rubbia-Brandt; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Alessandro Ferrero; Richard D Schulick; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.